Direct purchasers look to appeal dismissal of price-discrimination claim against Insulin manufacturers, pharmacy benefit managers
MLex Summary: Direct purchasers of insulin drugs have asked a US judge to enter a final judgment and allow them to appeal an order that dismissed their price-discrimination claim, arguing that...To view the full article, register now.
Already a subscriber? Click here to view full article